Xylem Inc. (NYSE:XYL) Receives $165.80 Average Price Target from Brokerages

Shares of Xylem Inc. (NYSE:XYL) have been assigned an average recommendation of “Moderate Buy” from the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $165.80.

XYL has been the subject of several research reports. Mizuho cut their price target on Xylem from $160.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, January 5th. William Blair started coverage on shares of Xylem in a research report on Monday. They set an “outperform” rating for the company. Zacks Research lowered shares of Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Argus set a $170.00 price objective on shares of Xylem in a research note on Wednesday, October 29th. Finally, Citigroup upped their target price on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th.

Xylem Stock Performance

XYL opened at $143.38 on Friday. Xylem has a 1-year low of $100.47 and a 1-year high of $154.27. The stock has a market cap of $34.91 billion, a P/E ratio of 36.86, a P/E/G ratio of 2.00 and a beta of 1.17. The stock’s 50 day simple moving average is $139.71 and its 200 day simple moving average is $141.69. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.Xylem’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.11 earnings per share. As a group, equities analysts anticipate that Xylem will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Insider Transactions at Xylem

In related news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president owned 31,250 shares in the company, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.27% of the company’s stock.

Institutional Trading of Xylem

A number of hedge funds have recently bought and sold shares of XYL. Vanguard Group Inc. lifted its stake in shares of Xylem by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 29,902,236 shares of the industrial products company’s stock worth $4,410,580,000 after purchasing an additional 204,407 shares during the period. State Street Corp increased its stake in Xylem by 1.2% in the third quarter. State Street Corp now owns 10,953,206 shares of the industrial products company’s stock valued at $1,615,598,000 after purchasing an additional 133,173 shares during the last quarter. Geode Capital Management LLC lifted its position in Xylem by 2.3% during the second quarter. Geode Capital Management LLC now owns 6,141,231 shares of the industrial products company’s stock worth $791,029,000 after buying an additional 136,605 shares during the period. Amundi lifted its position in Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock worth $730,717,000 after buying an additional 830,337 shares during the period. Finally, Impax Asset Management Group plc boosted its stake in Xylem by 13.7% in the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock worth $709,183,000 after buying an additional 663,191 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.